| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |